Tortoise Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-960
| Closed | -$41.4K | – | 732 |
|
|
2025
Q3 | $41.4K | Hold |
960
| – | – | ﹤0.01% | 423 |
|
|
2025
Q2 | $36.9K | Hold |
960
| – | – | ﹤0.01% | 424 |
|
|
2025
Q1 | $37.2K | Hold |
960
| – | – | ﹤0.01% | 412 |
|
|
2024
Q4 | $32.5K | Hold |
960
| – | – | ﹤0.01% | 489 |
|
|
2024
Q3 | $39.2K | Hold |
960
| – | – | ﹤0.01% | 451 |
|
|
2024
Q2 | $37K | Hold |
960
| – | – | ﹤0.01% | 431 |
|
|
2024
Q1 | $41.2K | Hold |
960
| – | – | 0.01% | 404 |
|
|
2023
Q4 | $35.6K | Hold |
960
| – | – | ﹤0.01% | 405 |
|
|
2023
Q3 | $34.8K | Hold |
960
| – | – | 0.01% | 386 |
|
|
2023
Q2 | $34.2K | Hold |
960
| – | – | 0.01% | 392 |
|
|
2023
Q1 | $34.2K | Hold |
960
| – | – | 0.01% | 377 |
|
|
2022
Q4 | $33.7K | Hold |
960
| – | – | 0.01% | 376 |
|
|
2022
Q3 | $28K | Hold |
960
| – | – | 0.01% | 383 |
|
|
2022
Q2 | $52K | Hold |
960
| – | – | 0.01% | 295 |
|
|
2022
Q1 | $52K | Buy |
+960
| New | +$52.1K | 0.01% | 299 |
|
|
2020
Q1 | – | Sell |
-546
| Closed | -$32K | – | 573 |
|
|
2019
Q4 | $32K | Hold |
546
| – | – | 0.01% | 275 |
|
|
2019
Q3 | $29K | Hold |
546
| – | – | 0.01% | 279 |
|
|
2019
Q2 | $27K | Hold |
546
| – | – | 0.01% | 304 |
|
|
2019
Q1 | $29K | Hold |
546
| – | – | 0.01% | 292 |
|
|
2018
Q4 | $26K | Hold |
546
| – | – | 0.01% | 290 |
|
|
2018
Q3 | $27K | Hold |
546
| – | – | 0.01% | 291 |
|
|
2018
Q2 | $28K | Hold |
546
| – | – | 0.01% | 292 |
|
|
2018
Q1 | $27K | Hold |
546
| – | – | 0.01% | 298 |
|
|
2017
Q4 | $24K | Hold |
546
| – | – | 0.01% | 303 |
|
|
2017
Q3 | $28K | Hold |
546
| – | – | 0.01% | 276 |
|
|
2017
Q2 | $29K | Sell |
546
-10
| -2% | -$533 | 0.01% | 260 |
|
|
2017
Q1 | $29K | Buy |
556
+10
| +2% | +$507 | 0.01% | 242 |
|
|
2016
Q4 | $26K | Buy |
+546
| New | +$27K | 0.01% | 247 |
|
|
2015
Q4 | – | Sell |
-146
| Closed | -$7K | – | 418 |
|
|
2015
Q3 | $7K | Hold |
146
| – | – | ﹤0.01% | 312 |
|
|
2015
Q2 | $8K | Hold |
146
| – | – | ﹤0.01% | 327 |
|
|
2015
Q1 | $8K | Hold |
146
| – | – | ﹤0.01% | 309 |
|
|
2014
Q4 | $8K | Hold |
146
| – | – | ﹤0.01% | 331 |
|
|
2014
Q3 | $8K | Hold |
146
| – | – | ﹤0.01% | 313 |
|
|
2014
Q2 | $10K | Hold |
146
| – | – | ﹤0.01% | 313 |
|
|
2014
Q1 | $10K | Hold |
146
| – | – | ﹤0.01% | 265 |
|
|
2013
Q4 | $10K | Hold |
146
| – | – | 0.01% | 245 |
|
|
2013
Q3 | $9K | Hold |
146
| – | – | 0.01% | 239 |
|
|
2013
Q2 | $9K | Buy |
+146
| New | +$9.27K | 0.01% | 235 |
|
Other funds holding GSK
JEST
Tortoise Investment Management's GSK Position: Q4 2025 in Review
Tortoise Investment Management sold out of GSK (GSK) in Q4 2025, closing a stake of 960 shares — an estimated $41.4K sold.
Tortoise Investment Management first reported a position in GSK in Q2 2013 and held it in 38 quarters. The position peaked at $52K in Q2 2022. 996 funds tracked by Wall St. Rank hold GSK as of Q4 2025.
- Tortoise Investment Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 960 GSK shares in Q4 2025, an estimated $41.4K.
- Tortoise Investment Management first reported a position in GSK in Q2 2013 and held it in 38 quarters.
- Tortoise Investment Management's GSK position peaked at $52K in Q2 2022.
- 996 funds tracked by Wall St. Rank held GSK as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.